期刊文献+

不同厂家小儿氨酚黄那敏颗粒剂及片剂分剂量的评价

Evaluation of Dose Splitting of Pediatric Paracetamol, Artificial Cow-bezoar and Chlorphenamine Maleate Granules and Tablets Manufactured by Different Pharmaceutical Factories
下载PDF
导出
摘要 目的:评价不同厂家小儿氨酚黄那敏颗粒剂及片剂分剂量的合理性,为提高临床用药水平提供依据。方法:比较11个厂家的小儿氨酚黄那敏颗粒剂及3个厂家的片剂分剂量成半袋(半片)理论装量(重量)与实际装量(重量)有无显著性差异、不同操作者实际装量(重量)有无显著性差异及半袋实际装量(重量)准确性。结果:A厂的小儿氨酚黄那敏颗粒剂流动性最佳,分剂量成半袋后,半袋理论装量与半袋实际装量无显著性差异(P>0.05),不同人员操作半袋实际装量无显著性差异(P>0.05),且准确性良好。结论:A厂的小儿氨酚黄那敏颗粒剂适合分半服用。 Objective: To evaluate rationality of dose splitting of pediatric paracetamol, artificial cow-bezoar and chlorphenamine maleate (short for PACBC) granules and tablets manufactured by different pharmaceutical factories to provide reference for clinical use. Method: Compared theoretical weight with actual weight,actual weight split by two pharmacy-majored operators and the accuracy of actual weight of PACBC granules produced by 11 companies and tablets produced by 3 companies. Results: The flowahility of PACBC granules produced by company A is the best of all. When split into half package, there is no significant difference between theoretical weight and actual weight, with the best accuracy. Conclusion: PACBC granules produced by company A is suitable for splitting into half to use.
出处 《清远职业技术学院学报》 2012年第6期9-11,共3页 Journal of Qingyuan Polytechnic
基金 清远市科技计划项目(编号:2011B011112080)
关键词 小儿 氨酚黄那敏 分剂量 Pediatrics Paracetamol, artificial cow-bezoar and chlorphenamine maleate Dose splitting
  • 相关文献

参考文献8

  • 1国家药典委员会.中国药典二部[S].2010:附录IN颗粒剂.
  • 2《中药、天然药物制荆研究的技术指导原则》课题研究组.中药、天然药物制荆研究的技术指导原则[s].2005:[z]GPH3-1.
  • 3European Pharmacopoeia Commission.Monograph 0478,European Pharmacopoeia [S].France:European Directorate for Quality Medicines,2008: 748-751.
  • 4平其能.现代药荆学[M].北京:中国医药工业出版社,1998.759-764
  • 5Broussard L. Small size, big risk:preventing neonatal and pediatric medication errors[J]. Nursing for Women's Health, 2010,14(05) : 405-407.
  • 6王亚敏.介绍欧洲医药品管理局儿童口服制剂研发技术指导原则[J].中国临床药理学杂志,2006,22(5):393-396. 被引量:10
  • 7陈趋源,夏克晶,程琳.用于包装散荆或颗粒荆药品的多室药袋[P].中国专利:201020297403.4,2010-08-19.
  • 8Van der Steen KC, Frijlink HW, Schipper CM, et al.Prediction of the ease of subdivision of scored tablets from their physical parameters:..AAPS PharmSciTech, 2010, 11(01):126-129.

二级参考文献6

  • 1Committee for Medicinal Products for Human Use (CHMP).Reflection Paper:Formulations of Choice for The Paediatric Population[J/OL].http://www.emea.eu.int,2005-06-23.
  • 2Committee for Medicinal Products for Human Use (CHMP).Guideline on The Role of Pharmacokinetics in The Development of Medicinal Products in The Paediatric Population (draft)[J/OL].http://www.emea.eu.int,2005 -02-17.
  • 3Pawar S,Kumar A.Issues in the formulation of drugs for oral use in children[J].Pediatric Drugs,2002 ,4:371-379.
  • 4Swarbrick J,Boylan JC.Encyclopedia of Pharmaceutical Technology[M].New York:Marcel Deker,2002:2053 -2056.
  • 5American Academy of Pediatrics,Committee on Drugs.Inactive ingredients in pharmaceutical products:update[J].Pediatrics,1997, 99:268 -278.
  • 6Littlewood JM,Wolfe SP.Control of malabsorbtion in cystic fibrosis[J].Paediatric Drugs,2000 ,2:205-222.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部